Peptide Chems

Wellness Research

CJC1295 DAC
Endocrine Research5mgInvestigationalCat. 2

CJC1295 DAC

GHRH analog studied in growth hormone pathway research.

Research Areas

GHRH receptor studies
Pituitary function research
Growth hormone axis investigations
Peptide pharmacokinetics studies

Scientific Background

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The DAC modification has been studied for its effects on extending the compound's pharmacokinetic profile.

Optimization & Cofactors

Published research on compounds that support this peptide's mechanisms

Cofactor information is compiled from published nutritional and biochemical research. This is educational content, not supplementation advice. Consult a qualified healthcare provider.

Glycine

3g before bed

Supports nocturnal GH release and sleep quality

Research Citation

Glycine enhances slow-wave sleep where GH secretion peaks

Zinc

25mg with lunch

Required for GH-IGF-1 axis function

Research Citation

Zinc deficiency impairs GH synthesis and secretion

Purity & Provenance

Why quality matters for research validity

CJC-1295 with DAC requires verification of peptide sequence and Drug Affinity Complex. The DAC extends half-life ~60-fold. HPLC ≥98% and mass spec confirmation essential.

Areas of Investigation

Endocrine researchGHRH studiesPeptide chemistry

Laboratory Information

Technical specifications for research settings

For Qualified Research Only

This compound is intended for qualified scientific research only. Not for human or veterinary use. Not for diagnostic or therapeutic applications. Researchers must comply with all applicable regulations in their jurisdiction.

Storage Conditions

Store at -20°C. Reconstituted solutions at 2-8°C.

Physical Form

Lyophilized powder

Purity

>97% by HPLC

Solubility

Soluble in bacteriostatic water

Research Notes

For in vitro endocrine research applications.

Deepen Your Research

Published literature and clinical trial registries

Published Literature

Published research has examined CJC-1295 DAC's molecular mechanisms and pharmacokinetic properties.

Regulatory Classification

Investigational

CJC-1295 is an investigational compound not available for compounding under current FDA regulations. For qualified research purposes only.

Important Research Notice

This information is compiled from scientific literature for educational purposes only. This website does not sell, distribute, or recommend any compounds for human use. All compounds discussed are for qualified research purposes only.